Preclinical safety is a crucial aspect of drug discovery and development. It aims to identify potential risks and toxicities associated with new drugs or therapies before they are tested in humans. At Biomex, we provide comprehensive preclinical safety services to support the drug discovery process and minimize the risk of harm to patients.

Our services include:

• ADME-Tox: Our ADME-Tox services evaluate the Absorption, Distribution, Metabolism, Excretion, and Toxicity of compounds through pharmacodynamic assays, in vivo efficacy studies, biomarker discovery, and safety evaluation.
• Immunogenicity-Immunotoxicity: Our immunogenicity-immunotoxicity services assess the potential for a drug to induce an immune response and cause harm to the immune system through antibody and cytokine assays.
  
  

At BIOMEX, we are dedicated to advancing your preclinical safety efforts and supporting your drug discovery and development goals.

Contact us to learn more about our services.